PDS Biotechnology CorporationPDSBNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-35.06M
↓ 31% below average
Average (9y)
$-26.81M
Historical baseline
Range
High:$-12.49M
Low:$-40.89M
CAGR
+4.8%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-35.06M | -4.2% |
| 2023 | $-33.64M | -30.8% |
| 2022 | $-25.71M | -105.9% |
| 2021 | $-12.49M | +5.0% |
| 2020 | $-13.15M | +27.2% |
| 2019 | $-18.07M | +45.5% |
| 2018 | $-33.15M | +18.9% |
| 2017 | $-40.89M | -24.4% |
| 2016 | $-32.88M | -42.6% |
| 2015 | $-23.06M | - |